MedMen Enterprises Inc.
MMNFF · OTC
6/25/2022 | 6/26/2021 | 6/30/2020 | 6/30/2019 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.01 | 0.01 | 0.00 | 0.19 |
| FCF Yield | -103.26% | -50.12% | -277.28% | -126.40% |
| EV / EBITDA | -7.15 | -11.36 | -3.94 | -2.72 |
| Quality | ||||
| ROIC | -50.03% | -30.47% | -43.12% | -43.13% |
| Gross Margin | 49.52% | 46.39% | 36.99% | 46.84% |
| Cash Conversion Ratio | 0.38 | 0.41 | 0.23 | 0.85 |
| Growth | ||||
| Revenue 3-Year CAGR | -3.59% | 3.73% | 58.07% | 265.04% |
| Free Cash Flow Growth | -6.98% | 60.53% | 53.05% | -183.46% |
| Safety | ||||
| Net Debt / EBITDA | -6.05 | -8.91 | -3.53 | -1.27 |
| Interest Coverage | -1.42 | -1.46 | -3.89 | -9.74 |
| Efficiency | ||||
| Inventory Turnover | 7.10 | 3.87 | 4.37 | 2.37 |
| Cash Conversion Cycle | -43.97 | 6.41 | -100.08 | -53.61 |